Overview

eotaxin


'eotaxin' can also refer to...

eotaxin

eotaxin

Eotaxin contributes to renal interstitial eosinophilia.

Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis

Diagnosis of Churg–Strauss syndrome: eotaxin-3 makes it easier

Control of extravillous trophoblast function by the eotaxins CCL11, CCL24 and CCL26

Eotaxin-3 in Churg–Strauss syndrome: a clinical and immunogenetic study

N-terminal domain of eotaxin-3 is important for activation of CC chemokine receptor 3

Th1-derived cytokine IFN-γ is a potent inhibitor of eotaxin synthesis in vitro

Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade

Association of Eotaxin gene family with asthma and serum total IgE

Association of Eotaxin gene family with asthma and serum total IgE

Eotaxin Expression in Onchocevca volvulus-Induced Dermatitis after Topical Application of Diethylcarbamazine

Eosinophils in the human corpus luteum: the role of RANTES and eotaxin in eosinophil attraction into periovulatory structures

Eotaxin-3 is involved in Churg–Strauss syndrome – a serum marker closely correlating with disease activity

Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions

Association between plasma levels of eotaxin (CCL-11) and treatment response to interferon-α and ribavirin in HIV/HCV co-infected patients

In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction

 

More Like This

Show all results sharing these subjects:

  • Medicine and Health
  • Chemistry

GO

Show Summary Details

Quick Reference

A chemokine (CCL11, 97 aa), originally described as being eosinophil-specific but subsequently shown to attract IL-2- and IL-4-stimulated T cells which, unlike naive T cells, express the CCR3 chemokine receptor.

Subjects: Medicine and Health — Chemistry.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.